Mortality in prostate cancer

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1084-1091

  Krongrad, Arnon ^a   Lai, Hong ^a   Lamm, Steven H ^a   Lai, Shenghan ^a  

^a NONE

Author keywords

mortality; prostatic neoplasms; risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0029782003     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65710-0     Document Type: Article

References (27)

1. Wingo, P. A., Tong, T. and Bolden, S.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M. and Warner, J.: Results of conservative management of clinically localized prostate cancer. New Engl. J. Med., 330: 242, 1994.
3. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. J.A.M.A., 274: 626, 1995.
4. Albertsen, P. C., Wasson, J. H. and Barry, M. J.: Observation as a treatment option among men with clinically localized prostate cancer. In: Prostate Cancer. Edited by N. A. Dawson and N. J. Vogelzang. New York: Wiley-Liss, Inc., pp. 185-196, 1994.
5. Catalona, W. J.: Expectant management and the natural history of localized prostate cancer. J. Urol., part 2, 152: 1751, 1994.
6. Wasson, J. H., Cushman, C. C., Bruskewitz, R. C., Littenberg, B., Mulley, A. G., Jr. and Wennberg, J. E.: A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. Arch. Fam. Med., 2: 487, 1993.
7. Lu-Yao, G. L., McLerran, D., Wasson, J. and Wennberg, J. E.: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcome Research Team. J.A.M.A., 269: 2633, 1993.
8. Zincke, H., Bergstralh, E. J., Blute, M. L., Myers, R. P., Barrett, D. M., Lieber, M. M., Martin, S. K. and Oesterling, J. E.: Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J. Clin. Oncol., 12: 2254, 1994.
9. Zietman, A. L., Coen, J. J., Dallow, K. C. and Shipley, W. U.: The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int. J. Rad. Oncol. Biol. Phys., 32: 287, 1995.
10. Schmidt, J. D., Mettlin, C. J., Natarajan, N., Peace, B. B., Beart, R. W., Jr., Winchester, D. P. and Murphy, G. P.: Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J. Urol., 136: 416, 1986.
11. Yancik, R. and Ries, L. A.: Cancer in older persons. Magnitude of the problem - how do we apply what we know? Cancer, suppl., 74: 1995, 1994.
12. Devesa, S. S., Silverman, D. T., Young, J. L., Jr., Pollack, E. S., Brown, C. C., Horm, J. W., Percy, C. L., Myers, M. H., McKay, F. W. and Fraumeni, J. F., Jr.: Cancer incidence and mortality trends among whites in the United States, 1947-84. J. Natl. Cancer Inst., 79: 701, 1987.
13. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
14. Cox, D. R.: Regression models and life tables. J. Roy. Stat. Soc., 34: 187, 1972.
15. Murphy, G. P. and Whitmore, W. F., Jr.: A report of the workshops on the current status of the histologie grading of prostate cancer. Cancer, 44: 1490, 1979.
16. Hanks, G. E., Diamond, J. J. and Kramer, S.: The need for complex technology in radiation oncology. Correlations of facility characteristics and structure with outcome. Cancer, suppl., 55: 2198, 1985.
17. Walsh, P. C.: Radical prostatectomy: a procedure in evolution. Sem. Oncol., 21: 662, 1994.
18. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Frehia, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
19. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. J.A.M.A., 251: 351, 1984.
20. Sarosdy, M. F.: Do we have a rational treatment plan for stage D-1 carcinoma of the prostate? World J. Urol., 33: 1, 1990.
21. Brawn, P. N., Johnson, E. H., Kuhl, D. L., Riggs, M. W., Speights, V. O., Johnson, C. F., III, Pandya, P. P., Lind, M. L. and Bell, N. F.: Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer, 71: 2569, 1993.
22. Mettlin, C. J., Murphy, G. P., McGinnis, L. S. and Menck, H. R.: The national cancer data base report on prostate cancer. Cancer, 76: 1104, 1995.
23. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. J.A.M.A., 274: 1599, 1995.
24. Dayal, H. H., Polissar, L. and Dahlberg, S.: Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J. Natl. Cancer Inst., 74: 1001, 1985.
25. Moul, J. W., Sesterhenn, I. A., Connelly, R. R., Douglas, T., Srivastava, S., Mostofi, F. K. and McLeod, D. G.: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. J.A.M.A., 274: 1277, 1995.
26. Aus, G., Hugosson, J. and Norlén, L.: Long-term survival and mortality in prostate cancer treated with noncurative intent. J. Urol., 154: 460, 1995.
27. Liu, W. L., Kasl, S., Flannery, J. T., Lindo, A. and Dubrow, R.: The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control, 6: 425, 1995.